The role of the low-FODMAP diet in the treatment of Irritable Bowel Syndrome - A Literature Review
DOI:
https://doi.org/10.12775/QS.2026.68.74528Keywords
IBS, FODMAP, low FODMAP diet, irritable bowel syndromAbstract
Background and Aims: Irritable bowel syndrome (IBS) is a common GI disorder that responds to dietary interventions, such as the low-FODMAP diet [1], and this review provides an overview of current evidence for its clinical efficacy and microbial impact.
Methods and Results: A growing body of data from systematic reviews and meta-analyses demonstrates that a low-FODMAP diet is highly effective in reducing overall GI symptoms in adults with IBS [2]; also, randomized crossover trials suggest that a patient\'s baseline symptom severity can predict their clinical response to the intervention[3]. The advantages of avoiding fermentable carbohydrates seem to extend beyond the lower GI tract, with the potential to also relieve comorbid dyspeptic symptoms[4]. Restricting these carbohydrates, however, has a profound effect on the ecosystem of the gut microbiota[5].
Conclusions: The low-FODMAP diet is an evidence-based approach for the treatment of IBS and other gastrointestinal disorders [2, 3], but given its known effects on the colonic microbiome, long-term compliance should be monitored to avoid changes in the microbiota [1, 5, 6].
References
[1] L. Bertin et al., “The Role of the FODMAP Diet in IBS,” Feb. 01, 2024, Multidisciplinary Digital Publishing Institute (MDPI). doi: 10.3390/nu16030370.
[2] A. S. van Lanen, A. de Bree, and A. Greyling, “Efficacy of a low-FODMAP diet in adult irritable bowel syndrome: a systematic review and meta-analysis,” Eur. J. Nutr., vol. 60, no. 6, pp. 3505–3522, Sep. 2021, doi: 10.1007/s00394-020-02473-0.
[3] J. P. Algera, D. Demir, H. Törnblom, S. Nybacka, M. Simrén, and S. Störsrud, “Low FODMAP diet reduces gastrointestinal symptoms in irritable bowel syndrome and clinical response could be predicted by symptom severity: A randomized crossover trial,” Clinical Nutrition, vol. 41, no. 12, pp. 2792–2800, Dec. 2022, doi: 10.1016/j.clnu.2022.11.001.
[4] S. Z. Hosseinian, F. Haghighatdoost, P. Hajihashemi, and P. Adibi, “The Effects of Fermentable Oligo-, Di-, and Monosaccharides and Polyols on Dyspeptic Symptoms: A Systematic Review and Meta-Analysis of Clinical Trials,” Jun. 01, 2026, John Wiley and Sons Inc. doi: 10.1002/hsr2.72662.
[5] H. Zhang and Q. Su, “Low-FODMAP Diet for Irritable Bowel Syndrome: Insights from Microbiome,” Feb. 01, 2025, Multidisciplinary Digital Publishing Institute (MDPI). doi: 10.3390/nu17030544.
[6] D. So, A. Loughman, and H. M. Staudacher, “Effects of a low FODMAP diet on the colonic microbiome in irritable bowel syndrome: a systematic review with meta-analysis,” Oct. 01, 2022, Oxford University Press. doi: 10.1093/ajcn/nqac176.
[7] Z. Khan, S. A. Muhammad, M. S. Amin, and A. Gul, “The Efficacy of the Low-FODMAP (Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols) Diet in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis,” Cureus, Jan. 2025, doi: 10.7759/cureus.77053.
[8] C. J. Black, H. M. Staudacher, and A. C. Ford, “Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis,” Gut, vol. 71, no. 6, pp. 1117–1126, 2022, doi: 10.1136/gutjnl-2021-325214.
[9] L. Kuźmin, K. Kubiak, and E. Lange, “Efficacy of a Low-FODMAP Diet on the Severity of Gastrointestinal Symptoms and Quality of Life in the Treatment of Gastrointestinal Disorders—A Systematic Review of Randomized Controlled Trials,” Jun. 01, 2025, Multidisciplinary Digital Publishing Institute (MDPI). doi: 10.3390/nu17122045.
[10] J. Hahn, J. Choi, and M. J. Chang, “Effect of low fodmaps diet on irritable bowel syndromes: A systematic review and meta-analysis of clinical trials,” Jul. 01, 2021, MDPI AG. doi: 10.3390/nu13072460.
[11] A. Ville et al., “Effects of a Low FODMAP Diet in Inflammatory Bowel Disease and Patient Experiences: A Mixed Methods Systematic Literature Review and Meta-Analysis,” Journal of Human Nutrition and Dietetics, vol. 38, no. 4, Aug. 2025, doi: 10.1111/jhn.70106.
[12] H. Haghbin et al., “Efficacy of Dietary Interventions for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis,” Dec. 01, 2024, Multidisciplinary Digital Publishing Institute (MDPI). doi: 10.3390/jcm13247531.
[13] J. Wang, P. Yang, L. Zhang, and X. Hou, “A Low-FODMAP Diet Improves the Global Symptoms and Bowel Habits of Adult IBS Patients: A Systematic Review and Meta-Analysis,” Aug. 19, 2021, Frontiers Media S.A. doi: 10.3389/fnut.2021.683191.
[14] H. Pourmand and A. Esmaillzadeh, “Consumption of a low fermentable oligo-, di-, mono-saccharides, and polyols diet and irritable bowel syndrome: A systematic review,” 2017, Wolters Kluwer Medknow Publications. doi: 10.4103/ijpvm.IJPVM_175_17.
[15] P. L. Zapata, E. G. Navarro, and C. R. Koninckx, “The low-FODMAP diet,” An. Pediatr. (Engl. Ed)., vol. 101, pp. 36–45, 2024, doi: 10.1016/j.anpede.2024.04.009.
[16] J. Dionne et al., “A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome,” Sep. 01, 2018, Nature Publishing Group. doi: 10.1038/s41395-018-0195-4.
[17] F. Melini, V. Melini, F. Luziatelli, A. G. Ficca, and M. Ruzzi, “Health-promoting components in fermented foods: An up-to-date systematic review,” May 01, 2019, MDPI AG. doi: 10.3390/nu11051189.
[18] J. E. Varney et al., “Clinical Trial: Effect of a 28-Day Low FODMAP Diet on Gastrointestinal Symptoms Associated With Endometriosis (EndoFOD)—A Randomised, Controlled Crossover Feeding Study,” Aliment. Pharmacol. Ther., vol. 61, no. 12, pp. 1889–1903, Jun. 2025, doi: 10.1111/apt.70161.
[19] C. N. Katsagoni, V. M. Karagianni, and A. Papadopoulou, “Efficacy of Different Dietary Patterns in the Treatment of Functional Gastrointestinal Disorders in Children and Adolescents: A Systematic Review of Intervention Studies,” Jun. 01, 2023, Multidisciplinary Digital Publishing Institute (MDPI). doi: 10.3390/nu15122708.
[20] J. P. Wielgosz-Grochowska, N. Domanski, and M. E. Drywień, “Efficacy of an Irritable Bowel Syndrome Diet in the Treatment of Small Intestinal Bacterial Overgrowth: A Narrative Review,” Aug. 01, 2022, MDPI. doi: 10.3390/nu14163382.
[21] M. G. Grammatikopoulou et al., “Low fodmap diet for functional gastrointestinal symptoms in quiescent inflammatory bowel disease: A systematic review of randomized controlled trials,” Dec. 01, 2020, MDPI AG. doi: 10.3390/nu12123648.
[22] D. Vandeputte and M. Joossens, “Effects of low and high FODMAP diets on human gastrointestinal microbiota composition in adults with intestinal diseases: A systematic review,” Nov. 01, 2020, MDPI AG. doi: 10.3390/microorganisms8111638.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Michalina Bąk, Karolina Stróżyk, Karolina Szamocka, Kajetan Kujawiński , Hanna Ruszkowska, Wiktor Zawadziński
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 126
Number of citations: 0
